Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea

Parkinsonism and Related Disorders

Volumn 17, Issue 8, 2011, Pages 593-598

  Bédard, Catherine ^a   Wallman, Marie Josée ^a   Pourcher, Emmanuelle ^a,b   Gould, Peter V ^c   Parent, André ^a   Parent, Martin ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b Clinique Sainte Anne   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Basal ganglia; Dopaminergic striatal innervation; Movement disorders; Neurodegenerative disorders; Serotoninergic striatal innervation

Indexed keywords

DOPAMINE; SEROTONIN; SEROTONIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; NERVE ENDING; NIGRONEOSTRIATAL SYSTEM; NUCLEUS ACCUMBENS; OPTICAL DENSITY; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 80052358717     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.05.012     Document Type: Article

References (30)

1. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995, 20:91-127.
2. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985, 44:559-577.
3. Di Matteo V., Pierucci M., Esposito E., Crescimanno G., Benigno A., Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog Brain Res 2008, 172:423-463.
4. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
5. Mai J.K., Paxinos G., Voss T. Atlas of the human brain 2008, Elsevier Academic Press, San Diego. 3rd ed.
6. Huot P., Parent A. Dopaminergic neurons intrinsic to the striatum. J Neurochem 2007, 101:1441-1447.
7. Ferrante R.J., Kowall N.W. Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum. Brain Res 1987, 416:141-146.
8. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Swahn C.G., et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 1997, 120(Pt 3):503-514.
9. Bohnen N.I., Koeppe R.A., Meyer P., Ficaro E., Wernette K., Kilbourn M.R., et al. Decreased striatal monoaminergic terminals in Huntington disease. Neurology 2000, 54:1753-1759.
10. Suzuki M., Desmond T.J., Albin R.L., Frey K.A. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse 2001, 41:329-336.
11. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455.
12. Bird E.D., Iversen L.L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 1974, 97:457-472.
13. McGeer P.L., McGeer E.G. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 1976, 26:65-76.
14. Spokes E.G. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. Brain 1980, 103:179-210.
15. Kish S.J., Shannak K., Hornykiewicz O. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum. Ann Neurol 1987, 22:386-389.
16. Bernheimer H., Birkmayer W., Hornykiewicz O. Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome. Klin Wochenschr 1961, 39:1056-1059.
17. Calon F., Morissette M., Rajput A.H., Hornykiewicz O., Bedard P.J., Di Paolo T. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications. Mov Disord 2003, 18:241-253.
18. Kish S.J., Tong J., Hornykiewicz O., Rajput A., Chang L.J., Guttman M., et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008, 131:120-131.
19. Cash R., Raisman R., Ploska A., Agid Y. High and low affinity [3H]imipramine binding sites in control and parkinsonian brains. Eur J Pharmacol 1985, 117:71-80.
20. Raisman R., Cash R., Agid Y. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen. Neurology 1986, 36:556-560.
21. Chinaglia G., Landwehrmeyer B., Probst A., Palacios J.M. Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram. Neuroscience 1993, 54:691-699.
22. Yamazoe I., Takeuchi Y., Matsushita H., Kawano H., Sawada T. Serotonergic heterotypic sprouting in the unilaterally dopamine-depleted mouse neostriatum. Dev Neurosci 2001, 23:78-83.
23. Descarries L., Soghomonian J.J., Garcia S., Doucet G., Bruno J.P. Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res 1992, 569:1-13.
24. Maeda T., Nagata K., Yoshida Y., Kannari K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain Res 2005, 1046:230-233.
25. Rozas G., Liste I., Guerra M.J., Labandeira-Garcia J.L. Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice. Neurosci Lett 1998, 245:151-154.
26. Gaspar P., Febvret A., Colombo J. Serotonergic sprouting in primate MTP-induced hemiparkinsonism. Exp Brain Res 1993, 96:100-106.
27. Guerra M.J., Liste I., Labandeira-Garcia J.L. Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. Neuroreport 1997, 8:3485-3488.
28. Carta M., Carlsson T., Munoz A., Kirik D., Bjorklund A. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Prog Brain Res 2008, 172:465-478.
29. Rylander D., Parent M., O'Sullivan S.S., Dovero S., Lees A.J., Bezard E., et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 2010, 68:619-628.
30. Reynolds G.P., Pearson S.J. Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci Lett 1987, 78:233-238.